Global Infertility Testing Market 2017 Size, Share, Growth, Trends, Type, Application, Analysis and Forecast by 2024
Global Infertility Testing Market is expected to reach 22,421.79 Million by 2024 from 13,347.10 in 2016, at a CAGR of 6.8% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
We Offer Free Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-infertility-testing-market
Major Players:
The Merck KGaA is going to dominate the global infertility market followed by-
· Procter & Gamble,
· bioMérieux
Other players operating in this market are include
· Babystart Ltd,
· Biozhena Corporation,
· Quidel Corporation,
· Alere Inc.,
· Biomérieux SA,
· SPD Swiss Precision Diagnostics GmBH,
· Proctor & Gamble,
· SCSA Diagnostics, Inc.,
· Among others…
Segmentation:
· By Type (Female Infertility Testing, Male Infertility Testing),
· By Test Kits (Human Follicular Stimulating Hormone (FSH) Urine Test Kits, Luteinizing Hormone (LH) Urine Test Kits, Human Chorionic Gonadotropin (HCG) Hormone Blood Test Kits, Others),
· By Prescription Mode (Prescription-Based, Over The Counter (OTC) Based),
· By Distribution Channel (Hospitals Pharmacies, Online Pharmacies, Pharmacies & Drug Stores),
· By End User (Fertility Centers, Hospitals And Clinics, Research Institutes, Cryobanks),
· By Geography (North America, Europe, Asia-Pacific, South America, Middle East And Africa)
Drivers:
· The major factors driving the growth of this market are significant decline in fertility rates, increasing number of fertility clinics, rising public awareness among the female population, increasing number of gynecological disorders and technological advancements and innovative testing products.
Free Inquire for Updated Report or Customization as Per Requirement @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-infertility-testing-market
TECHNOLOGICAL CHANGES SUCH AS LOW GWP REFRIGERANTS
· In October 2016, Episona Inc., an epigenetics data company which deals in improving the reproductive health launched the Seed, an innovative new male fertility test. Seed analyzes epigenetic changes on DNA to personalize fertility treatment and potentially decrease time to pregnancy.
· In December 2016, Medical Electronic Systems (MES), manufacturer of commercial-grade automated semen analyzers and gold standard in automated semen analysis launched the YO Home Sperm Test.
Exclusive News on Infertility Testing Report @ https://databridgemarketresearch.com/news/product-launch/global-infertility-testing-market/
About Us:
Data Bridge Market Research adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us-
Data Bridge Market Research
US: +1–888–387–2818
Email: sopan.gedam@databridgemarketresearch.com
Website: https://databridgemarketresearch.com
We Offer Free Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-infertility-testing-market
Major Players:
The Merck KGaA is going to dominate the global infertility market followed by-
· Procter & Gamble,
· bioMérieux
Other players operating in this market are include
· Babystart Ltd,
· Biozhena Corporation,
· Quidel Corporation,
· Alere Inc.,
· Biomérieux SA,
· SPD Swiss Precision Diagnostics GmBH,
· Proctor & Gamble,
· SCSA Diagnostics, Inc.,
· Among others…
Segmentation:
· By Type (Female Infertility Testing, Male Infertility Testing),
· By Test Kits (Human Follicular Stimulating Hormone (FSH) Urine Test Kits, Luteinizing Hormone (LH) Urine Test Kits, Human Chorionic Gonadotropin (HCG) Hormone Blood Test Kits, Others),
· By Prescription Mode (Prescription-Based, Over The Counter (OTC) Based),
· By Distribution Channel (Hospitals Pharmacies, Online Pharmacies, Pharmacies & Drug Stores),
· By End User (Fertility Centers, Hospitals And Clinics, Research Institutes, Cryobanks),
· By Geography (North America, Europe, Asia-Pacific, South America, Middle East And Africa)
Drivers:
· The major factors driving the growth of this market are significant decline in fertility rates, increasing number of fertility clinics, rising public awareness among the female population, increasing number of gynecological disorders and technological advancements and innovative testing products.
Free Inquire for Updated Report or Customization as Per Requirement @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-infertility-testing-market
TECHNOLOGICAL CHANGES SUCH AS LOW GWP REFRIGERANTS
· In October 2016, Episona Inc., an epigenetics data company which deals in improving the reproductive health launched the Seed, an innovative new male fertility test. Seed analyzes epigenetic changes on DNA to personalize fertility treatment and potentially decrease time to pregnancy.
· In December 2016, Medical Electronic Systems (MES), manufacturer of commercial-grade automated semen analyzers and gold standard in automated semen analysis launched the YO Home Sperm Test.
Exclusive News on Infertility Testing Report @ https://databridgemarketresearch.com/news/product-launch/global-infertility-testing-market/
About Us:
Data Bridge Market Research adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us-
Data Bridge Market Research
US: +1–888–387–2818
Email: sopan.gedam@databridgemarketresearch.com
Website: https://databridgemarketresearch.com